These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22223137)

  • 1. Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed.
    Li Q; Kawamura K; Yamanaka M; Okamoto S; Yang S; Yamauchi S; Fukamachi T; Kobayashi H; Tada Y; Takiguchi Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    Cancer Gene Ther; 2012 Mar; 19(3):218-28. PubMed ID: 22223137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E1B-55 kDa-defective adenoviruses activate p53 in mesothelioma and enhance cytotoxicity of anticancer agents.
    Yamanaka M; Tada Y; Kawamura K; Li Q; Okamoto S; Chai K; Yokoi S; Liang M; Fukamachi T; Kobayashi H; Yamaguchi N; Kitamura A; Shimada H; Hiroshima K; Takiguchi Y; Tatsumi K; Tagawa M
    J Thorac Oncol; 2012 Dec; 7(12):1850-1857. PubMed ID: 23154556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An MDM2 inhibitor achieves synergistic cytotoxic effects with adenoviruses lacking E1B55kDa gene on mesothelioma with the wild-type p53 through augmenting NFI expression.
    Nguyen TTT; Shingyoji M; Hanazono M; Zhong B; Morinaga T; Tada Y; Shimada H; Hiroshima K; Tagawa M
    Cell Death Dis; 2021 Jul; 12(7):663. PubMed ID: 34230456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma.
    Hopkins-Donaldson S; Belyanskaya LL; Simões-Wüst AP; Sigrist B; Kurtz S; Zangemeister-Wittke U; Stahel R
    Neoplasia; 2006 Jul; 8(7):551-9. PubMed ID: 16867217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-β produces synergistic combinatory anti-tumor effects with cisplatin or pemetrexed on mesothelioma cells.
    Li Q; Kawamura K; Yang S; Okamoto S; Kobayashi H; Tada Y; Sekine I; Takiguchi Y; Shingyouji M; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    PLoS One; 2013; 8(8):e72709. PubMed ID: 23977343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronic acid produces antitumor effects on mesothelioma through apoptosis and S-phase arrest in p53-independent and Ras prenylation-independent manners.
    Okamoto S; Kawamura K; Li Q; Yamanaka M; Yang S; Fukamachi T; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Kobayashi H; Tagawa M
    J Thorac Oncol; 2012 May; 7(5):873-82. PubMed ID: 22481236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma.
    Jiang Y; Zhong B; Kawamura K; Morinaga T; Shingyoji M; Sekine I; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    BMC Cancer; 2016 Jul; 16():455. PubMed ID: 27405588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
    Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T
    Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma.
    Anraku M; Tagawa T; Wu L; Yun Z; Keshavjee S; Zhang L; Johnston MR; de Perrot M
    J Immunol; 2010 Jul; 185(2):956-66. PubMed ID: 20548032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma.
    Vandermeers F; Hubert P; Delvenne P; Mascaux C; Grigoriu B; Burny A; Scherpereel A; Willems L
    Clin Cancer Res; 2009 Apr; 15(8):2818-28. PubMed ID: 19351772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.
    Spugnini EP; Cardillo I; Verdina A; Crispi S; Saviozzi S; Calogero R; Nebbioso A; Altucci L; Cortese G; Galati R; Chien J; Shridhar V; Vincenzi B; Citro G; Cognetti F; Sacchi A; Baldi A
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6133-43. PubMed ID: 17062690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Maulik G; Mukhopadhyay L; Yeap BY; Kindler HL; Salgia R; Sugarbaker DJ; Bueno R
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):549-58. PubMed ID: 17522864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].
    Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levels.
    Okamoto S; Jiang Y; Kawamura K; Shingyoji M; Fukamachi T; Tada Y; Takiguchi Y; Tatsumi K; Shimada H; Hiroshima K; Kobayashi H; Tagawa M
    PLoS One; 2013; 8(3):e60297. PubMed ID: 23555949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo.
    Tsai NM; Lin SZ; Lee CC; Chen SP; Su HC; Chang WL; Harn HJ
    Clin Cancer Res; 2005 May; 11(9):3475-84. PubMed ID: 15867250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.
    Yang CT; You L; Uematsu K; Yeh CC; McCormick F; Jablons DM
    Cancer Res; 2001 Aug; 61(16):5959-63. PubMed ID: 11507034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
    Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.
    Hemmati PG; Normand G; Verdoodt B; von Haefen C; Hasenjäger A; Güner D; Wendt J; Dörken B; Daniel PT
    Oncogene; 2005 Jun; 24(25):4114-28. PubMed ID: 15750619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.